Related Experiment Video
Updated: Oct 28, 2026

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
Published on: July 23, 2016
Therapeutic delivery systems need to focus on cellular precision to target neurodegeneration
Lavanya Gupta1, Sinem Agilkaya1, Kim Susann Keller1
1School of Life Sciences, Reutlingen University, Reutlingen, Germany.
Abstract:
The central problem when delivering drugs to the brain is no longer crossing the blood-brain barrier, but delivering therapeutics to the right cells, in the right regions to target neurodegeneration, within a dynamically changing neurovascular unit.
More Related Videos
09:19High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
Published on: January 4, 2015
04:41Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice
Published on: February 24, 2026
Related Concept Videos
Modified-Release Drug Delivery Systems: Site-Targeted
Modified-Release Drug Delivery Systems: Classification
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Transdermal Drug Delivery Systems